中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
24期
26-29
,共4页
王娟%胡建铭%黄亚珍%陈友国
王娟%鬍建銘%黃亞珍%陳友國
왕연%호건명%황아진%진우국
血细胞比容%子痫前期%妊娠结局
血細胞比容%子癇前期%妊娠結跼
혈세포비용%자간전기%임신결국
Hematocrit%Preeclampsia%Pregnancy outcome
目的:探讨妊娠晚期血细胞比容(HCT)与子痫前期患者妊娠结局的关系。方法选择2012年5月1日~2014年5月6日在苏州大学附属第一医院产科生产的子痫前期患者92例为研究对象。所有患者于产前1周内检测清晨空腹血HCT、血红蛋白水平和平均动脉压,详细记录患者的年龄、妊娠次数等。探讨患者HCT和妊娠结局的关系。结果患者平均年龄(27.9±4.9)岁,多次妊娠的患者57例(62.0%),重度子痫前期59例(64.1%),HCT(0.336±0.048)、血红蛋白水平(111.7±17.5)g/L,贫血41例(44.6%)。重度子痫前期患者HCT(0.337±0.051)略高于轻度子痫前期者(0.334±0.043),差异无统计学意义(P>0.05)。早产的子痫前期患者HCT(0.339±0.056)高于非早产的患者(0.333±0.040),差异无统计学意义(P>0.05)。分娩低体重新生儿的子痫前期患者HCT值(0.396±0.057)显著高于正常体重新生儿的子痫前期患者(0.328±0.032),差异有统计学意义(P<0.05)。Pearson直线相关分析结果显示,子痫前期患者妊娠晚期HCT与血红蛋白水平呈直线正相关(r=0.945,P<0.001);子痫前期患者妊娠晚期HCT与新生儿体重呈直线负相关(r=-0.276,P<0.05),而与新生儿胎龄无相关性(P>0.05)。结论子痫前期患者妊娠晚期HCT的升高增加了分娩低体重新生儿的风险,不增加早产的风险,与重度子痫前期无显著相关性。
目的:探討妊娠晚期血細胞比容(HCT)與子癇前期患者妊娠結跼的關繫。方法選擇2012年5月1日~2014年5月6日在囌州大學附屬第一醫院產科生產的子癇前期患者92例為研究對象。所有患者于產前1週內檢測清晨空腹血HCT、血紅蛋白水平和平均動脈壓,詳細記錄患者的年齡、妊娠次數等。探討患者HCT和妊娠結跼的關繫。結果患者平均年齡(27.9±4.9)歲,多次妊娠的患者57例(62.0%),重度子癇前期59例(64.1%),HCT(0.336±0.048)、血紅蛋白水平(111.7±17.5)g/L,貧血41例(44.6%)。重度子癇前期患者HCT(0.337±0.051)略高于輕度子癇前期者(0.334±0.043),差異無統計學意義(P>0.05)。早產的子癇前期患者HCT(0.339±0.056)高于非早產的患者(0.333±0.040),差異無統計學意義(P>0.05)。分娩低體重新生兒的子癇前期患者HCT值(0.396±0.057)顯著高于正常體重新生兒的子癇前期患者(0.328±0.032),差異有統計學意義(P<0.05)。Pearson直線相關分析結果顯示,子癇前期患者妊娠晚期HCT與血紅蛋白水平呈直線正相關(r=0.945,P<0.001);子癇前期患者妊娠晚期HCT與新生兒體重呈直線負相關(r=-0.276,P<0.05),而與新生兒胎齡無相關性(P>0.05)。結論子癇前期患者妊娠晚期HCT的升高增加瞭分娩低體重新生兒的風險,不增加早產的風險,與重度子癇前期無顯著相關性。
목적:탐토임신만기혈세포비용(HCT)여자간전기환자임신결국적관계。방법선택2012년5월1일~2014년5월6일재소주대학부속제일의원산과생산적자간전기환자92례위연구대상。소유환자우산전1주내검측청신공복혈HCT、혈홍단백수평화평균동맥압,상세기록환자적년령、임신차수등。탐토환자HCT화임신결국적관계。결과환자평균년령(27.9±4.9)세,다차임신적환자57례(62.0%),중도자간전기59례(64.1%),HCT(0.336±0.048)、혈홍단백수평(111.7±17.5)g/L,빈혈41례(44.6%)。중도자간전기환자HCT(0.337±0.051)략고우경도자간전기자(0.334±0.043),차이무통계학의의(P>0.05)。조산적자간전기환자HCT(0.339±0.056)고우비조산적환자(0.333±0.040),차이무통계학의의(P>0.05)。분면저체중신생인적자간전기환자HCT치(0.396±0.057)현저고우정상체중신생인적자간전기환자(0.328±0.032),차이유통계학의의(P<0.05)。Pearson직선상관분석결과현시,자간전기환자임신만기HCT여혈홍단백수평정직선정상관(r=0.945,P<0.001);자간전기환자임신만기HCT여신생인체중정직선부상관(r=-0.276,P<0.05),이여신생인태령무상관성(P>0.05)。결론자간전기환자임신만기HCT적승고증가료분면저체중신생인적풍험,불증가조산적풍험,여중도자간전기무현저상관성。
Objective To investigate the relationship between maternal hematocrit (HCT) and pregnancy outcome in women with preeclampsia. Methods 92 patients with preeclampsia from 1st May, 2012 to 6th May, 2014 in the First Affiliated Hospital of Soochow University were included. Hematocrit, hemoglobin, and mean arterial pressure of the patients were detected during one week before the birth giving, age and number of pregnancies were collected. The connection of hematocrit and pregnancy outcomes was analyzed Neonatal birth weight and gestational age were evaluated. Results The average age of patients was (27.9±4.9) years, 57 cases (62.0%) with more than once pregnancy, 59 cases of severe preeclampsia (64.1%), HCT values was (0.336±0.048), hemoglobin values was (111.7±17.5)g/L, 41 anemia cases(44.6%). Maternal HCT was higher in women with severe preeclampsia (0.337±0.051) than those with mild preeclampsia (0.334±0.043), but there was no statistically significant difference (P > 0.05). Maternal HCT was similar in women with preterm (0.339±0.056) and without preterm (0.333±0.040), there was no statistically significant difference (P > 0.05). Maternal HCT was significantly higher in women with low birth weight delivery (0.396±0.057) than those with normal birth weight delivery (0.328±0.032), the difference was statistically significant (P < 0.05). Maternal HCT was significantly positive related to maternal hemoglobin concentrations (r=0.945, P<0.001) and negative correlation to low birth weight (r=-0.276, P<0.05). Maternal HCT was not significantly associated with preterm (r=-0.149, P>0.05). Conclusion Elevated HCT remarkably increases the risk of low birth weight, but not preterm in pregnancy with preeclampsia.